Statistics for ARCA biopharma (id:5962 ABIO)
Valuation metrics
Market cap
34.82M
Enterprise value
3.01M
Trailing P/E (ttm)
-55.41
Forward P/E
-3.27
PEG ratio
-3.27
Price/Sales (ttm)
Price/Book (mrq)
12.83
Enterprise Value/Revenue
Enterprise Value/EBITDA
-0.35
Overview
Shares outstanding
1.21M
Float
4.79M
Shares short
4.99M
% Held by insiders
0.01%
% Held by institutions
1.01%
Average volume (10 days)
107.84K
Average volume (90 days)
Price summary
52-Week low
18.72
52-Week high
53.88
52-Week change
-14.15%
Beta
0.90
50-Day moving average
39.21
200-Day moving average
30.93
Dividends and splits
Forward annual dividend rate
6.36
Forward annual dividend yield
0.31
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
Payout ratio
0.00
Dividend date
August 28th, 2024
Ex-dividend date
August 29th, 2024
Last split factor
2:1
Last split date
April 04th, 2019
Financials
Fiscal yearFiscal year ends
December 31th, 2023
Most recent quarter (mrq)
June 30th, 2024
Profitability
Profit margin
0.00%
Operating margin
0.00%
Operational effectiveness
Return on assets
-14.35%
Return on equity
-20.05%
Income statement
Revenue (ttm)
0.00
Revenue per share (ttm)
0.00
Quarterly revenue growth (yoy)
Gross profit (ttm)
0.00
EBITDA
-8,589,000.00
Net income to common (ttm)
-7,200,000.00
Diluted EPS (ttm)
-5.88
Quarterly earnings growth (yoy)
Balance sheet
Total cash (mrq)
33.28M
Total cash per share (mrq)
2.29
Total debt (mrq)
24.00K
Total Debt/Equity (mrq)
0.07
Current ratio (mrq)
2.66K%
Book value per share (mrq)
2.24
Cash flow
Cash flow statement
-6,887,000.00
Levered free cash flow (LFCF)
-4,978,250.00